Tecentriq
Loading Map....
Tecentriq the First Approved Immunotherapy for PDL-1+ mTNBC
Featured Faculty
Debbie Tuttle, DNP, FNP-BC, AOCNS, CBCN
Oncology Nurse Practitioner
Stanford Cancer Center
Palo Alto, CA
Tecentriq the First Approved Immunotherapy for PDL-1+ mTNBC
Featured Faculty
Debbie Tuttle, DNP, FNP-BC, AOCNS, CBCN
Oncology Nurse Practitioner
Stanford Cancer Center
Palo Alto, CA